tiprankstipranks
Silo Pharma exercises options for exclusive license agreement
PremiumThe FlySilo Pharma exercises options for exclusive license agreement
1M ago
Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain
PremiumPress Releases
Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain
2M ago
Silo Pharma files patent for ketamine implant therapeutic
PremiumThe Fly
Silo Pharma files patent for ketamine implant therapeutic
2M ago
Silo Pharma Prioritizes Mental Health in 2024 Pipeline
PremiumCompany AnnouncementsSilo Pharma Prioritizes Mental Health in 2024 Pipeline
3M ago
Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology
PremiumPress Releases
Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology
3M ago
Silo Pharma preparing pre-IND application for lead drug program SPC-15
PremiumThe Fly
Silo Pharma preparing pre-IND application for lead drug program SPC-15
3M ago
Silo Pharma completes first phase of dose-ranging study of SPC-15
PremiumThe FlySilo Pharma completes first phase of dose-ranging study of SPC-15
4M ago
Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia
PremiumPress Releases
Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia
4M ago
Silo Pharma receives approval to begin development of ketamine implant
PremiumThe Fly
Silo Pharma receives approval to begin development of ketamine implant
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100